Although the promoter TSER polymorphism was identified in a cis-acting enhancer element of the TYMS gene and is thought to affect TYMS mRNA expression [16,17,22], several molecular epidemiological studies reported contrary results of the associations between this variant and cancer risk [19,23-34]. The gene discussed is TYMS; the disease is cancer.